Caitong International Asset Management’s Zevra Therapeutics ZVRA Stock Holding History

Caitong International Asset Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.8K	Buy	4,377 +4,278	+4,321%	+$47.6K	0.01%	659
2026 Q1	$923	Sell	99 -293	-75%	-$2.64K	﹤0.01%	1460
2025 Q4	$3.51K	Buy	392 +197	+101%	+$1.86K	﹤0.01%	1274
2025 Q3	$1.85K	Sell	195 -323	-62%	-$3.24K	﹤0.01%	1394
2025 Q2	$4.56K	Sell	518 -77	-13%	-$625	﹤0.01%	1055
2025 Q1	$4.46K	Buy	+595	New	+$4.73K	﹤0.01%	1049

Other funds holding ZVRA

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

IFG Advisors St. Louis, Missouri $725M AUM 27.52% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Caitong International Asset Management's ZVRA Position: Q2 2026 in Review

Caitong International Asset Management increased its Zevra Therapeutics (ZVRA) stake by 4,321% in Q2 2026, buying an estimated $47.6K and bringing the position to 4,377 shares worth $62.8K. The position accounts for 0.01% of the portfolio, ranked #659.

Caitong International Asset Management first reported a position in ZVRA in Q1 2025 and has held it in 6 quarters since. 36 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

Caitong International Asset Management held 4,377 shares of Zevra Therapeutics worth $62.8K as of Q2 2026.
Caitong International Asset Management bought 4,278 Zevra Therapeutics shares in Q2 2026, an estimated $47.6K.
Zevra Therapeutics made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #659 holding.
Caitong International Asset Management first reported a position in Zevra Therapeutics in Q1 2025 and has held it in 6 quarters since.
36 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.